Revvity | Capital Ordinário

Preço das Ações
104.49
Mudança Diária
1.67 1.62%
Mensal
0.58%
Anual
-7.22%
Q1 Previsão
98.47




Capital Ordinário Alterar Data
Agilent USD 283.05M 540K 2025-09
Align Technology USD 71.75M 736K 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 27.06M 571K 2025-06
Bruker USD 151.72M 149.92M 2025-09
Celltrion KRW 218.78M 1.5M 2025-09
Charles River Laboratories USD 49.22M 6K 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Danaher USD 706.9M 600K 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Exact Sciences USD 189.45M 232K 2025-09
Hologic USD 222.57M 350K 2025-09
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Kangmei Pharma CNY 13.86B 0 2025-06
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 82.9M 75.3M 2025-06
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 115.01M 9.28M 2024-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.1M 0 2025-09
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
OraSure Technologies USD 0 0 2024-06
Organigram Holdings CAD 134.46M 438.86K 2025-09
Pacific Biosciences Of California USD 258K 8K 2023-09
Pharma Mar EUR 17.58M 0 2025-09
Qiagen NV USD 216.56M 284.67K 2025-12
Quest Diagnostics USD 111M 1000K 2025-09
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.28M 30K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Sartorius EUR 69.04M 0 2025-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Tilray USD 1.06B 86.93M 2025-03
Waters USD 98.08M 38.55M 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09


Revvity Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.